Hualiang Pharmaceutical released the monthly report on securities changes as of December 31, 2024, on January 7, 2025. The report shows that the company's registered capital and the number of issued shares remain unchanged.The company's registered capital is maintained at 2,000,000,000 ordinary shares, with a par value of $0.001 per share, totaling $2,000,000. The total number of issued shares remains at 1,055,588,761 shares, with no treasury shares.According to the stock option plan after the initial public offering, the company has granted a total of 52,357,591 stock options, convertible into 43,796,608 shares. No new shares were issued or stock options were exercised during this month.

Hualiang Pharmaceutical released the monthly report on securities changes as of December 31, 2024, on January 7, 2025. The report shows that the company's registered capital and the number of issued shares remain unchanged.The company's registered capital is maintained at 2,000,000,000 ordinary shares, with a par value of $0.001 per share, totaling $2,000,000. The total number of issued shares remains at 1,055,588,761 shares, with no treasury shares.According to the stock option plan after the initial public offering, the company has granted a total of 52,357,591 stock options, convertible into 43,796,608 shares. No new shares were issued or stock options were exercised during this month.